Digestive System Diseases: News and Research on Inflammatory Bowel Diseases

MeSH tree: C06.405.469.432

FDA approves Tremfya for ulcerative colitis

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.

page 34 from 40